Find out about TECregen's, a Basel-based company developing novel biologics designed to rejuvenate the thymus, “thymopoietics ...

Systemic therapy for sarcoidosis is reserved for organ-threatening disease, and laryngeal involvement necessitates treatment ...

LYNX-3, the second pivotal Phase 3 trial in keratorefractive participants with visual disturbances under mesopic, low-contrast conditions, is ongoing with topline results expected in the first half of ...

In idiopathic pulmonary fibrosis, 12 months of pulmonary rehabilitation increased cerebral oxygenation during exercise, ...

Cellino, a regenerative medicine company developing autonomous manufacturing systems for personalized cells, announced a strategic collaboration with Polyphron, a company developing an autonomous ...

Something we can get a handle on this year is our health, and there’s no better time than January to set a precedent for this ...

Learn why smart contract audits are essential for bridge security. Know how independent evaluations detect vulnerabilities ...

Addressing the microbiome's translational gap involves understanding biological complexity and developing function-driven, patient-specific interventions.

At 13, Functional Neurological Disorder changed Liam’s life—the EHCP activities that may seem “non-educational” helped him back outside ...

A great all-rounder, Dove’s gradual tanner helps build a natural glow with minimal effort. The lotion can be applied with ...

MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss ...

How do cross-chain asset transfers work? Learn how blockchain bridges move tokens between networks using lock-and-mint ...